PD Dr. Hans Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry (2023) Blank N, Kötter I, Schmalzing M, Rech J, Krause K, Köhler B, Kaudewitz D, et al. Journal article Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis (2023) Birkner B, Rech J, Edelmann E, Verheyen F, Schett G, Stargardt T Journal article Erratum to: Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guideline (Zeitschrift für Rheumatologie, (2022), 10.1007/s00393-022-01294-2) (2023) Vordenbäumen S, Feist E, Rech J, Fleck M, Blank N, Haas JP, Kötter I, et al. Journal article, Erratum Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Brandt-Jürgens J, Burmester GR, Kellner H, et al. Journal article Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline (2022) Vordenbaeumen S, Feist E, Rech J, Fleck M, Blank N, Haas JP, Koetter I, et al. Journal article Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still's disease-associated hemophagocytic lymphohistiocytosis-a case report (2022) Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, Schorr J, et al. Journal article, Letter Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry (2022) Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Schuetz C, Kallinich T, et al. Conference contribution Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial (2022) Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Rech J, Burmester G, et al. Conference contribution Entheseal Biopsy Approach: An Ultrasound-guided Method for Retrieval of Entheseal Tissue from Psoriatic Arthritis Patients (2022) Raimondo MG, Pachowsky M, Xu C, Rauber S, Tascilar K, Labinsky H, Vogg M, et al. Conference contribution